Pulse Biosciences, Inc.
(NASDAQ : PLSE)

( )
PLSE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -1.42%535.901.0%$658.29m
DHRDanaher Corp. -1.72%252.010.7%$646.03m
MDTMedtronic Plc -1.36%89.240.6%$617.50m
ABTAbbott Laboratories -1.93%106.980.8%$595.35m
ISRGIntuitive Surgical, Inc. -2.86%201.990.8%$426.39m
BSXBoston Scientific Corp. -0.87%37.491.0%$336.88m
ALGNAlign Technology, Inc. -3.30%241.926.4%$298.14m
EWEdwards Lifesciences Corp. -2.16%94.720.4%$272.21m
BDXBecton, Dickinson & Co. -2.21%244.581.0%$270.07m
SYKStryker Corp. -2.37%198.321.3%$261.62m
IDXXIDEXX Laboratories, Inc. -2.74%349.213.8%$224.75m
AAgilent Technologies, Inc. -2.87%117.111.7%$210.64m
BAXBaxter International, Inc. -2.11%65.301.8%$203.22m
SWAVShockwave Medical, Inc. -1.33%195.540.0%$174.99m
DXCMDexCom, Inc. -2.48%74.701.9%$172.48m

Company Profile

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.